help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Portaluppi, F.
Right arrow Articles by Lugaresi, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Portaluppi, F.
Right arrow Articles by Lugaresi, E.

Journal of Clinical Endocrinology & Metabolism, Vol 78, 1075-1078, Copyright © 1994 by Endocrine Society

ARTICLES

Progressive disruption of the circadian rhythm of melatonin in fatal familial insomnia

F Portaluppi, P Cortelli, P Avoni, L Vergnani, P Maltoni, A Pavani, E Sforza, EC Degli Uberti, P Gambetti and E Lugaresi
Institute of Internal Medicine, University of Ferrara, Italy.

Fatal familial insomnia (FFI) is a disease characterized by loss of sleep activity due to selective thalamic degeneration. To assess the secretory pattern of melatonin (MT) in FFI, we studied two cases of overt disease under standardized conditions and polysomnographic control. Each patient underwent repeated 24-h study sessions, and MT was assayed at 30-min intervals. Six healthy volunteers were used as controls. Slow wave sleep was never recorded, whereas occasional episodes of enacted dreaming accompanied by rapid ocular movements and complex muscular activities were documented, with no detectable rhythm. Plasma MT concentrations gradually decreased as the disease progressed. A significant circadian rhythm was detected in the earlier recordings, with decreasing amplitudes with disease progression. Complete rhythm obliteration was achieved in the most advanced stage. Normally placed nocturnal acrophases were detected in the earlier stages, but then a shift toward the daytime hours was observed. Thalamic lesions of FFI appear to determine a progressive disruption of the sleep/wake cycle accompanied by decreased circulating levels of MT, with progressive alterations in the circadian rhythm of this hormone. On the other hand, decreased secretion of MT may contribute to the sleep disturbances of FFI.


This article has been cited by other articles:


Home page
 BrainHome page
P. Cortelli, D. Perani, P. Montagna, R. Gallassi, P. Tinuper, P. Federica, P. Avoni, F. Ferrillo, D. Anchisi, R. M. Moresco, et al.
Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies
Brain, March 1, 2006; 129(3): 668 - 675.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
I. Tobler, T. Deboer, and M. Fischer
Sleep and Sleep Regulation in Normal and Prion Protein-Deficient Mice
J. Neurosci., March 1, 1997; 17(5): 1869 - 1879.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society